Dr. Frangoul Discusses CRISPR's Impact on Treating Sickle Cell Disease - BCN

In a live interview with BCN's Tashanea Whitlow, Medical Director of the Pediatric Hematology and Oncology for Sarah Cannon and the Children's Hospital, Dr. Haydar Frangoul explains how a new gene therapy is showing promise for thousands of people in the U.S. battling sickle cell anemia.